Biggest News Aggregation in the World
📰 Acticor Biotech News

Page 3 - Acticor Biotech News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Acticor Biotech. Real-time updates on events, politics, business and more.

Acticor Biotech: Disclosure of The Total Number of Voting Rights and Shares as of March 31, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies
France General Newton Biocapital European Medicines Agency French National Institute Of Health Regulation Of The French Financial Markets Authority Venture Investment

DelveInsight Business Research, LLP: Extremely Robust Acute Respiratory Distress Syndrome Pipeline Featuring 100+ Companies Expected to Change the Pace of the ARDS Treatment

The rise in the incidence of ARDS stimulates the research and development of the drug, as it is likely to provide an appropriate environment for newer products to be profitable. Companies across
Prnewswire Delveinsight Inflammtory Demyelinating Polyneuropathy Verona Pharma Boehringer Ingelheim Genentech Synact Pharma Sarconeos Zavegepant

Acticor Biotech Publishes Its 2022 Annual Results and Provides an Update on Its Clinical Progress

23.03.2023 - Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, today released its ...
United Kingdom Czech Republic France General United States Great Britain Newton Biocapital

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of February 28, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies
France General Dennis Riedl Newton Biocapital Venture Investment French National Institute Of Health Regulation Of The French Financial Markets Authority

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of January 31, 2023

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies
France General Newton Biocapital Schwierige Zeiten Venture Investment French National Institute Of Health Regulation Of The French Financial Markets Authority

Acticor Biotech Announces the Appointment of Patricia Zilliox to the Board of Directors as an Indepe

PARIS--(BUSINESS WIRE)--Regulatory News:ACTICOR BIOTECH (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, is announcing today the appointment of Patricia Zilliox as a...
United States France General Newton Biocapital Corinne Le Goff Patricia Zilliox Alain Munoz

Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies
France General Newton Biocapital Kepler Cheuvreux Venture Investment French National Institute Of Health European Medicines Agency

Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2022

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies
France General Newton Biocapital Venture Investment French National Institute Of Health Regulation Of The French Financial Markets Authority European Medicines Agency

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science